No surrogate in toxicology studies; mouse surrogate M702 was developed for in vivo studies as tezepelumab does not bind mouse TSLP
“Because of the lack of binding of tezepelumab to mouse TSLP, M702, a mouse surrogate antibody was developed for in vivo studies.”
✓ VerifiedEMA assessment report, p. 27Source ↗